CHG-2022-0287
Shelf Life Extension for Thymosilib. New Dosage Strength for Thymosilib — critical change. Impacts 4 markets and 3 variations.
Change Number
CHG-2022-0287
Type
Shelf Life Extension
Product
Status
Submitted
Owner
Sarah Chen
Initiated
2022-05-09
Description
New Dosage Strength for Thymosilib — critical change
Impacted Markets (4)
CH — SwitzerlandSG — SingaporeZA — South AfricaBE — Belgium
Impacted Modules
2.3.P5.3.53.2.P
Linked Variations (0)
| Variation # | Type | Application | Status | Submitted | Approved |
|---|